Overview
Microcephaly-thin corpus callosum-intellectual disability syndrome is an extremely rare genetic condition that affects brain development. The name describes its three main features: microcephaly (a head that is smaller than expected), a thin corpus callosum (the bundle of nerve fibers that connects the two halves of the brain), and intellectual disability. Because the brain does not develop as expected, children with this condition typically have delays in learning, speech, and motor skills. This syndrome falls under a group of conditions sometimes called "microcephaly with associated brain abnormalities." The thin corpus callosum means that communication between the left and right sides of the brain may be reduced, which can contribute to difficulties with coordination, problem-solving, and language. Some affected individuals may also experience seizures, behavioral challenges, and problems with muscle tone. There is currently no cure for this condition. Treatment focuses on managing symptoms and supporting development. This may include physical therapy, occupational therapy, speech therapy, and medications to control seizures if they occur. Early intervention programs can help children reach their fullest potential. A team of specialists typically works together to provide comprehensive care tailored to each individual's needs.
Key symptoms:
Smaller than normal head size (microcephaly)Intellectual disabilityDelayed speech and language developmentDelayed motor milestones such as sitting and walkingSeizures or epilepsyLow muscle tone (floppiness) or increased muscle stiffnessDifficulty with coordination and balanceBehavioral challengesLearning difficultiesShort stature or poor growthFeeding difficulties in infancyAbnormal brain structure visible on MRI
Clinical phenotype terms (18)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Microcephaly-thin corpus callosum-intellectual disability syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Microcephaly-thin corpus callosum-intellectual disability syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Microcephaly-thin corpus callosum-intellectual disability syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Microcephaly-thin corpus callosum-intellectual disability syndrome.
Community
No community posts yet. Be the first to share your experience with Microcephaly-thin corpus callosum-intellectual disability syndrome.
Start the conversation →Latest news about Microcephaly-thin corpus callosum-intellectual disability syndrome
No recent news articles for Microcephaly-thin corpus callosum-intellectual disability syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific genetic change is causing my child's condition, and does it help predict how they will develop?,What therapies should we start right away to support my child's development?,Is my child at risk for seizures, and what should I watch for?,How often should we have brain imaging or other follow-up tests?,Are there any clinical trials or research studies my child might be eligible for?,What is the chance that future children could have the same condition?,What resources and support services are available for our family?
Common questions about Microcephaly-thin corpus callosum-intellectual disability syndrome
What is Microcephaly-thin corpus callosum-intellectual disability syndrome?
Microcephaly-thin corpus callosum-intellectual disability syndrome is an extremely rare genetic condition that affects brain development. The name describes its three main features: microcephaly (a head that is smaller than expected), a thin corpus callosum (the bundle of nerve fibers that connects the two halves of the brain), and intellectual disability. Because the brain does not develop as expected, children with this condition typically have delays in learning, speech, and motor skills. This syndrome falls under a group of conditions sometimes called "microcephaly with associated brain a
How is Microcephaly-thin corpus callosum-intellectual disability syndrome inherited?
Microcephaly-thin corpus callosum-intellectual disability syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Microcephaly-thin corpus callosum-intellectual disability syndrome typically begin?
Typical onset of Microcephaly-thin corpus callosum-intellectual disability syndrome is neonatal. Age of onset can vary across affected individuals.